Open AccessExperience with 274 Cardiac Transplant Recipients with Posttransplant Lymphoproliferative Disorder: A Report from the Israel Penn International Transplant Tumor Registry
Author(s) -
Meredith J. Aull,
Joseph F. Buell,
Jennifer Trofe,
M. Roy First,
Rita R. Alloway,
Michael J. Hanaway,
Lynne E. Wagoner,
Thomas G. Gross,
Thomas M. Beebe,
E. Steve Woodle
Publication year - 2004
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000144333.19106.58
Subject(s) - immunosuppression , medicine , post transplant lymphoproliferative disorder , transplantation , sudden cardiac death , lymphoproliferative disorders , complication , rituximab , lymphoma
Posttransplant lymphoproliferative disorder (PTLD) is a life-threatening complication that occurs in a small but significant minority of solid organ transplant recipients. Published experiences with PTLD in cardiac transplant recipients are limited to relatively small single-center reports.